Characteristics of the Clostridium difficile cell envelope and its importance in therapeutics.
Clostridium difficile infection (CDI) is a challenging threat to human health. Infections occur after disruption of the normal microbiota, most commonly through the use of antibiotics. Current treatment for CDI largely relies on the broad-spectrum antibiotics vancomycin and metronidazole that further disrupt the microbiota resulting in frequent recurrence, highlighting the need for C. difficile-specific antimicrobials. The cell surface of C. difficile represents a promising target for the development of new drugs. C. difficile possesses a highly deacetylated peptidoglycan cell wall containing unique secondary cell wall polymers. Bound to the cell wall is an essential S-layer, formed of SlpA and decorated with an additional 28 related proteins. In addition to the S-layer, many other cell surface proteins have been identified, including several with roles in host colonization. This review aims to summarize our current understanding of these different C. difficile cell surface components and their viability as therapeutic targets.
Krebs Institute, Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, S10 2TN, UK.
Joseph A
JA
Kirk
Krebs Institute, Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, S10 2TN, UK.
Oishik
O
Banerji
Krebs Institute, Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, S10 2TN, UK.
Robert P
0000-0002-8704-4828
RP
Fagan
D001426:Bacterial Proteins / Q000032:analysis*; D002473:Cell Wall / Q000737:chemistry*; D016360:Clostridioides difficile / Q000737:chemistry*; D008562:Membrane Glycoproteins / Q000032:analysis*; D010457:Peptidoglycan / Q000032:analysis*
D001426:Bacterial Proteins; D008562:Membrane Glycoproteins; D010457:Peptidoglycan; C055764:S-layer proteins; C070683:surface layer protein A, Bacteria